Article information
Full text is only aviable in PDF
Bibliografía
[1.]
J.E. Heffner, J.E. Repine.
Pulmonary strategies of antioxidant defense.
Am Rev Respir Dis, 140 (1989), pp. 531-554
[2.]
Forman HJ. Oxidant radical production and lung injury. En: Das DK, Essman WB, eds. Oxygen radicáis: Systemic events and Disease Processes. Basel, Karger, 1990; 71-96.
[3.]
I.U. Schraufstatter, P.A. Hyslop, J. Jackson, S.D. Revak, C.C. Cochrane.
Oxidant and protease injury of the lung.
Bull Eur Physiopathol Resp, 23 (1987), pp. 297-302
[4.]
Klebanoff SJ. Phagocytic cells: Products of oxygen metabolism. En: Gallin JI, Goldstein IM, Synderman R, ed. Inflammation: Basic principies and clinical correlates. 1988; 391-444.
[5.]
P.A. Southorn, G. Powis.
Free radicáis in medicine. I. Chemical nature and biological reactions.
Mayo Clin Proc, 63 (1988), pp. 381-389
[6.]
C.F. Nathan.
Secretion of oxygen intermediates: role in effector function of activated macrophages.
Fed Proc, 41 (1982), pp. 2.206-2.211
[7.]
B.A. Freeman, J.D. Crapo.
Free radicáis and tissue injury.
Lab Invest, 47 (1982), pp. 412-426
[8.]
C.E. Cross, B. Halliwell, E.T. Borisch, W.A. Pryor, B.N. Ames, R.L. Saúl, et al.
Oxygen radicáis and human disease.
Ann Intern Med, 107 (1987), pp. 526-545
[9.]
S.R. Baldwin, C.M. Grum, L.A. Boxer, R.H. Simón, L.H. Ketai, L.J. Devall.
Oxidant activity in expired breath of patients with adult respiratory distress syndrome.
Lancet, 1 (1986), pp. 11-13
[10.]
C.C. Cochrane, R. Spraggs, S.D. Revak.
Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid.
J Clin Invest, 71 (1983), pp. 754-761
[11.]
W.J. Martin, D.L. Kachel.
Bleomycin-induced pulmonary endothelial cell injury: evidence for the role of iron-catalized toxic oxygen-derived species.
J Lab Clin Med, 110 (1987), pp. 153-158
[12.]
W.J. Martin.
Nitrofurantoin: Evidence for the oxidant injury of lung parenchymal cells.
Am Rev Respir Dis, 127 (1983), pp. 482-486
[13.]
S.J. Weiss.
Tissue destruction by neutrophils.
N Engl J Med, 320 (1989), pp. 365-376
[14.]
J.L. Pérez Arellano, J.E. Losa García, M.J. García Martín, M.C. Alcázar Montero, M. Cordero Sánchez, A. Jiménez López.
Organización funcional del macrófago alveolar.
Arch Bronconeumol, 26 (1990), pp. 305-316
[15.]
S. Chollet-Martin, C. Pasquier, C.I. Marquetty, et al.
Cytochrome b-245 in human alveolar macrophages.
Am Rev Respir Dis, 132 (1985), pp. 836-838
[16.]
M. Nakamura, S. Sendo, R. van Zwieten, T. Loga, D. Roos, S. Kanegasaki.
Immunocytochemical discovery of the 22-to 23-Kd subunit of cytochrome b-558 at the surface of human peripheral phagocytes.
Blood, 72 (1988), pp. 1.550-1.552
[17.]
T. Yamaguchi, M. Kaneda.
Presence of cytochrome b-558 in guinea-pig alveolar subcellular localization and relationship with NADPH oxidase.
Biochim Biophys Acta, 933 (1988), pp. 450-459
[18.]
R.N. Harada, A.E. Vatter, J.E. Repine.
Oxygen radical scavengers protect alveolar macrophages from hyperoxic injury in vitro.
Am Rev Respir Dis, 128 (1983), pp. 761-762
[19.]
R.F. Jacobs, P.M. Locksley, C.B. Wilson, J.E. Haas, S.J. Klebanoff.
Interaction of primate alveolar macrophages and Legionella pneumophila.
J Clin Invest, 73 (1984), pp. 1.515-1.523
[20.]
K.J. Johnson, P.A. Ward, R.G. Kunkel, B.S. Wilson.
Mediation of IgA induced lung injury in the rat: role of macrophages and reactive oxygen species.
Lab Invest, 54 (1986), pp. 499-506
[21.]
M.J. Bishop, E.Y. Chi, M. Su, F.W. Cheney.
Dimethyltiourea not ameliorate reperfusion lung injury in dogs and rabbits.
J Appl Physiol, 65 (1988), pp. 2.051-2.056
[22.]
M.A. Shatos, J.M. Doherty, J.P. Marsh, B.T. Mossman.
Prevention of asbestos-induced cell death in rat lung fibroblast and alveolar macrophages by scavengers of active oxygen species.
Environ Res, 44 (1987), pp. 103-116
[23.]
N.W. Boyce, P.G. Tipping, S.R. Holsworth.
Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis.
Kidney Intern, 35 (1989), pp. 778-782
[24.]
W.D. Biggar, J.M. Sturgess.
Peroxidase activity of alveolar macrophages.
Lab Invest, 24 (1976), pp. 31-42
[25.]
D. Sandron, H.Y. Reynolds, A.M. Laval, A. Venet, D. Israel-Biet, J. Chretien.
Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients.
Eur J Respir Dis, 68 (1986), pp. 177-185
[26.]
J.B.L. Gee, C.L. Vassallo, M.T. Vogt, C. Thomas, R.E. Basford.
Peroxidative metabolism in alveolar macrophages.
Arch Intern Med, 127 (1971), pp. 1.046-1.049
[27.]
B.B. Paul, R.R. Strauss, R.J. Selvaraj, A.J. Sbarra.
Peroxidase mediated antimicrobial activities on alveolar macrophage granules.
Science, 181 (1973), pp. 849-850
[28.]
H.J. Forman, E. Kim.
Inhibition by linoleic acid hydroperoxide of alveolar macrophage superoxide production: Effects upon mitochondrial and plasma membrane potentials.
Arch Biochem Biophys, 274 (1989), pp. 443-452
[29.]
P.H.S. Sporn, M. Peters-Golden, R.H. Simón.
Hydrogen-peroxideinduced arachidonic acid metabolism in the rat alveolar macrophage.
Am Rev Respir Dis, 137 (1988), pp. 49-56
[30.]
P.H.S. Sporn, M. Peters-Golden.
Hydrogen peroxide inhibits alveolar macrophage 5-lypooxigenase metabolism in association with depletion of ATP.
J Biol Chem, 263 (1988), pp. 14.776-14.783
[31.]
P.H.S. Sporn, T.M. Marshall, M. Peters-Golden.
Differential dependence on protein kinase C of arachidonic acid metabolism stimulated by hydrogen peroxide and by zymosan in the alveolar macrophage.
Biochem Biophys Acta, 1.047 (1990), pp. 187-191
[32.]
G. Chaudhri, I.A. Clark.
Reactive oxygen species facilítate the in vitro and in vivo lipo polysaccharide-induced release of tumor necrosis factor.
J Immunol, 143 (1989), pp. 1.290-1.294
[33.]
R.J. McDonald, E.M. Berger, J.E. Repine.
Alveolar macrophage antioxidants prevent hydrogen peroxide-mediated lung damage.
Am Rev Respir Dis, 143 (1991), pp. 1.088-1.091
[34.]
R.J. Helmke, V.F. Germán, J.A. Mangos.
A continuous alveolar macrophage cell line: compari sons with freshly derived alveolar macrophages.
In Vitro Cell Develop Biol, 25 (1989), pp. 44-48
[35.]
J.R. Hoidal, G.D. Beall, F.L. Rasp, B. Holmes, J.G. White, J.E. Repine.
Comparison of the metabolism of alveolar macrophages from humans, rats, and rabbits: response to heat-killed bacteria or phorbol myristate acétate.
J Lab Clin Med, 92 (1978), pp. 787-794
[36.]
S.J. O’Neill, S.K. Hoehn, R. Lesperance, D.J. Klass.
Functional heterogeneity of isopycnic fractions of rat alveolar macrophages.
Infect Immun, 46 (1984), pp. 282-284
[37.]
D.B. Drath.
Enhanced superoxide release and tumoricidal activity by a postlavage, in situ pulmonary macrophage population in response to activation by Mycobacterium bovis BCG exposure.
Infect Immun, 49 (1985), pp. 72-75
[38.]
R.B. Zeidler, J.A. Flynn, J.C. Arnold, N.S. Conley.
Subpopulation of alveolar macrophages inhibits superoxide anión production by macrophages.
Inflammation, 11 (1987), pp. 371-379
[39.]
W.J. Calhoun, S.M. Salisbury.
Heterogeneity in cell recovery and superoxide production in buoyant, density defíned subpopulations of human alveolar macrophages from healthy volunteers and sarcoidosis patients.
J Lab Clin Med, 114 (1989), pp. 682-690
[40.]
P.O. Oyunbiyi, H.P. Misra.
Alterations of guinea pig alveolar macrophage oxidative metabolism by nicotine.
Tox Appl Pharmacol, 98 (1989), pp. 25-30
[41.]
J. Milanowski, J. Dutkiewicz.
Increased superoxide anión generation by alveolar macrophages stimulated with antigens associated with organic dusts.
Allergol Immunopathol, 18 (1990), pp. 211-215
[42.]
J.B. Galvin, S.G. Oberg.
Toxicity of hexavalent chromium to the alveolar macrophage in vivo and in vitro.
Environ Res, 33 (1984), pp. 7-16
[43.]
M. Joseph, A.B. Tonnel, A. Capron, C. Voisin.
Enzyme release and superoxide anión production by human alveolar macrophages stimulated with immunoglobulin E.
Clin Exp Immunol, 40 (1980), pp. 416-422
[44.]
R.W. Fuller, P.K. Morris, R. Richmond, D. Sykes, I.M. Varndell, D.M. Kemeny, et al.
Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type I hypersensitivity.
Clin Exp Immunol, 65 (1986), pp. 416-426
[45.]
P.A. Ward, R.E. Duque, M.C. Sulavik, K.J. Johnson.
In vitro and in. vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes.
Production of O2 and H2O2. Am J Pathol, 110 (1983), pp. 297-309
[46.]
G. Benichou, G.A. Voisin.
Antibody bipolar brinding: isotypedependent signals given to guinea pig alveolar macrophages by anti-MHC alloantibodies.
Cell Immunol, 106 (1987), pp. 304-317
[47.]
W.J. Calhoun, C.A. Stevens, S.B. Lambert.
Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by p-agonists and theophylline.
J Lab Clin Med, 117 (1991), pp. 514-522
[48.]
P.A.J. Henricks, B. van Esch, A.J.M. van Oosterhout, F.P. Nijkamp.
Specific and nonspecific effects of p-adrenoceptor agonists on guinea pig alveolar macrophage function.
Eur J Phar Macol, 152 (1988), pp. 321-330
[49.]
Y. Kakuta, T. Kato, H. Sasaki, T. Takishima.
Effect of ketotifen on human alveolar macrophages.
J Allergy Clin Immunol, 81 (1988), pp. 469-474
[50.]
K. Winsel, H. Grollmuss, U. Unger, H. Eckert.
Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid.
Z Erkr Atmungsorgane, 165 (1985), pp. 149-162
[51.]
L.M. Ingraham, R.S. Weening, M.F. Clarke, L.A. Boxer, R.L. Baehner.
Relation of respiratory burst and arachidonate metabolism during phagocytosis by guinea pig alveolar macrophages.
J Lab Clin Med, 99 (1982), pp. 908-916
[52.]
J. Chang, S. Piperata, M. Skowronek, A.J. Lewis.
Effects of thiazinamium chloride, pro methazine and chlorpromazine on thromboxane B2 synthesis, phagocytosis and respiratory burst by rat alveolar macrophages.
Biochem Pharmacol, 32 (1983), pp. 2.671-2.677
[53.]
J.H. Williams, S. Heshmati, S. Tamadon, J. Guerra.
Inhibition of alveolar macrophages by pentoxifylline.
Crit Care Med, 19 (1991), pp. 1.073-1.078
[54.]
K. Donaldson, J. Slight, R.E. Bolton.
The effect of products from bronchoalveolar derived neutrophils on oxidant production and phagocytic activity of alveolar macrophages.
Clin Exp Immunol, 74 (1988), pp. 477-482
[55.]
M.J. Rock, J. Despot, R.F. Lemanske.
Mast cell granules modulate alveolar macrophage respiratory-burst activity and eicosanoid metabolism.
J Allergy Clin Immunol, 86 (1990), pp. 452-461
[56.]
A.O.S. Fels, C.F. Nathan, Z.A. Cohn.
Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons a, p, y and 1,25-dihydroxy-vitamin D3.
J Clin Invest, (1987), pp. 381-386
[57.]
B. Kemmerich, T.H. Rossing, J.E. Pennington.
Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon.
Am Rev Respir Dis, 136 (1987), pp. 266-270
[58.]
A.K. Sharp, D.K. Banerjee.
Effect of gamma interferon on hydrogen peroxide production by cultured mouse peritoneal macrophages.
Infect Immun, 54 (1986), pp. 597-599
[59.]
A. Dwenger, G. Regel, B. Ellendorff, et al.
Alveolar cell pattern and chemiluminescence response of blood neutrophils and alveolar macrophages in sheep after endotoxin injection.
J Clin Chem Clin Biochem, 28 (1990), pp. 163-168
[60.]
R.F. Jacobs, D.P. Kiel, R.A. Balk.
Alveolar macrophage function in a canine model of endotoxin-induced lung injury.
Am Rev Respir Dis, 134 (1986), pp. 745-751
[61.]
J.G.N. García, M.B. Perlman, T.J. Ferro, A. Johnson, W. Jubiz, A.B. Malik.
Inflammatory events after fibrin microembolization. Alterations in alveolar macrophage and neutrophil function.
Am Rev Respir Dis, 137 (1988), pp. 630-635
[62.]
H.J. Forman, J. Nelson, G. Harrison.
Hyperoxia alters effect of calcium on rat alveolar macrophage superoxide production.
J Appl Physiol, 60 (1986), pp. 1.300-1.305
[63.]
V. Moshenin, J. Latifpour.
Respiratory burst in alveolar macrophages of diabetic rats.
J Appl Physiol, 68 (1990), pp. 2.384-2.390
[64.]
J.K. Brieland, R.G. Kunkel, J.C. Fantone.
Pulmonary alveolar macrophage function during acute inflammatory lung injury.
Am Rev Respir Dis, 135 (1987), pp. 1.300-1.306
[65.]
M.L. Sánchez Benítez de Soto.
Intervención de los radicales libres de oxígeno en la patogenia de la neumonitis por hipersensibilidad.
Tesis Doctoral, Universidad de Salamanca, (1992),
[66.]
M.L. Sánchez, T. Martín, N. Barrios, C. González, A. Jiménez, J.L. Pérez Arellano.
Generación de radicales libres de oxígeno en la neumonitis por hipersensibilidad experimental en cobayas.
Simposium Internacional Lavado Broncoalveolar,, (1993),
[67.]
R.P. Baughman, E.E. Lower, G. Pierson, S. Strohofer.
Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers.
J Lab Clin Med, 111 (1988), pp. 399-404
[68.]
A.P. Greening, D.B. Lowrie.
Extracellular release of hydrogen peroxide by human alveolar macrophages: the relationship to cigarette smoking and lower respiratory tract infection.
Clin Sci, 65 (1983), pp. 661-664
[69.]
W.B. Davis, E. Pacht, M. Spatafora, W.J. Martin.
Enhanced cytotoxic potential of alveolar macrophages from cigarette smokers.
J Lab Clin Med, 111 (1988), pp. 293-298
[70.]
H. Bergstrand, A. Björnson, E. Blaschke, et al.
Effects of an inhaled corticosteroid, budesonide on alveolar macrophage function in smokers.
Thorax, 45 (1990), pp. 362-368
[71.]
K. McCusker, J. Hoidal.
Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke-exposed hamsters.
Am Rev Respir Dis, 141 (1990), pp. 678-682
[72.]
S.E. McGowan, C.M. Parenti, J.R. Hoidal, D.W. Niewoehner.
Differences in ascorbic acid content and accumulation by alveolar macrophages from cigarette smokers and non-smokers.
J Lab Clin Med, 104 (1984), pp. 127-134
[73.]
S.E. McGowan, J.J. Murray, M.G. Parrish.
Iron binding, internalization, and fate in human alveolar macrophages.
J Lab Clin Med, 108 (1986), pp. 587-595
[74.]
S.E. McGowan, S.A. Henley.
Iron and ferritin contents and distribution in human alveolar macrophages.
J Lab Clin Med, 111 (1988), pp. 611-617
[75.]
E.A. Rich.
Iron metabolism by smokers’ alveolar macrophages: protective or problematic in the lung?.
J Lab Clin Med, 111 (1988), pp. 598-599
[76.]
E.R. Pacht, H. Kaseki, J.R. Mohammed, D.G. Dornwell, W.B. Davis.
Deficiency of Vitamin E in the alveolar fluid of cigarette smokers.
J Clin Invest, 77 (1986), pp. 789-796
[77.]
E.R. Pacht, W.B. Davis.
Decreased ceruloplasmin ferroxidase activity in cigarette smokers.
J Lab Clin Med, 111 (1988), pp. 661-668
[78.]
M. Damon, M. Cluzel, P. Chanez, P.H. Godard.
Phagocytosis induction of chemiluminescence and chemoattractant increased superoxide anion release from activated human alveolar macrophages in asthma.
J Biolum Chemilum, 4 (1989), pp. 279-286
[79.]
M. Cluzel, M. Damon, P. Chanez, J. Bousquet, A. Crastes de Paulet, F.B. Michel, P.H. Godard.
Enhanced alveolar cell luminoldependent chemiluminescence in asthma.
J Allergy Clin Immunol, 80 (1987), pp. 195-201
[80.]
R.R. Martin, E.C. Lawrence, R.B. Teague, M.S. Gottlieb, M. Putman.
Chemiluminescence of lung macrophages and blood leukocytes in sarcoidosis.
Am Rev Respir Dis, 133 (1986), pp. 298-301
[81.]
W.J. Calhoun, S.M. Salisbury, L.W. Chosy, W.W. Busse.
Increased. alveolar macrophage chemiluminescence and airspace cell superoxide production in active pulmonary sarcoidosis.
J Lab Clin Med, 112 (1988), pp. 147-156
[82.]
M.A. Cassatella, G. Berton, C. Agostini, R. Zambello, L. Trentin, A. Cipriani, G. Semenzato.
Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.
Immunology, 66 (1989), pp. 451-458
[83.]
J. Strausz, J. Müller-Quernheim, H. Steppling, R. Ferlinz.
Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis.
Am Rev Respir Dis, 141 (1990), pp. 124-128
[84.]
J. Kiemle-Kallee, H. Kreipe, H.J. Radzum, et al.
Alveolar macrophages in idiopathic pulmonary fibrosis display a more monocyte-like immunophenotype and increases release of free oxygen radicals.
Eur Respir J, 4 (1991), pp. 400-406
[85.]
T.H. Pérez, J.M. Farre, P.H. Gosset, et al.
Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages.
Eur Respir J, 2 (1989), pp. 7-13
[86.]
A.M. Cantin, R.C. Hubbard, R.G. Crystal.
Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis.
Am Rev Respir Dis, 139 (1989), pp. 370-372
[87.]
B. Wallaert, C. Aerts, F. Bart, et al.
Alveolar macrophage dysfunction in systemic lupus erythematosus.
Am Rev Respir Dis, 136 (1987), pp. 293-297
[88.]
W.J. Calhoun.
Enhanced reactive oxygen species metabolism of air space cells in hypersensitivity pneumonitis.
J Lab Clin Med, 117 (1991), pp. 443-452
[89.]
A. Clement, K. Chadelat, A. Sardet, A. Grimfeld, G. Tournier.
Alveolar macrophage status in bronchopulmonary dysplasia.
Ped Res, 23 (1988), pp. 470-473
[90.]
B. Wallaert, P. Bonniere, L. Prin, A. Cortot, A.B. Tonnel, C. Voisin.
Primary biliary cirrhosis. Sub clinical inflammatory alveolitis in patients with normal chest roentgenograms.
Chest, 90 (1986), pp. 842-848
[91.]
B. Wallaert, P. Lassalle, F. Fortin, et al.
Superoxide anion generation by alveolar inflammatory cells in simple pneumoconiosis and in Progressive massive fibrosis of nonsmoking coal workers.
Am Rev Respir Dis, 141 (1990), pp. 129-133
[92.]
H.S.R. Hosker, P.A. Corris.
Alveolar macrophage and blood monocyte function in lung cancer.
Canc Detect Prevent, 15 (1991), pp. 103-106
[93.]
J.R. Hoidal, R.B. Fox, J.E. Repine.
Defective oxidative metabolic response in vitro of alveolar macrophages in chronic granulomatous disease.
Am Rev Respir Dis, 120 (1979), pp. 613-618
Copyright © 1993. Sociedad Española de Neumología y Cirugía Torácica
